Integrated Investment Consultants, LLC Pfizer Inc Transaction History

Integrated Investment Consultants, LLC

$4.55 Billion
Q3 2024

A detailed history of Integrated Investment Consultants, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 112,885 shares of PFE stock, worth $2.96 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

112,885

Previous 21,975 413.7%

Holding current value

$2.96 Million

Previous $614,000 431.92%

% of portfolio

0.07%

Previous 0.18%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $2.52 Million - $2.85 Million	90,910 Added 413.7%	112,885 $3.27 Million
Q1 2024 Apr 18, 2024	SELL	$25.89 - $29.73 $123,106 - $141,366	-4,755 Reduced 17.79%	21,975 $609,000
Q4 2023 May 28, 2024	BUY	$26.13 - $33.94 $124,823 - $162,131	4,777 Added 23.45%	25,151 $724,000
Q4 2023 Jan 23, 2024	BUY	$26.13 - $33.94 $124,875 - $162,199	4,779 Added 21.77%	26,730 $769,000
Q3 2023 May 28, 2024	SELL	$32.09 - $37.51 $51,376 - $60,053	-1,601 Reduced 7.29%	20,374 $675,000
Q3 2023 Oct 17, 2023	SELL	$32.09 - $37.51 $11,969 - $13,991	-373 Reduced 1.67%	21,951 $728,000
Q2 2023 Jul 18, 2023	BUY	$36.12 - $41.79 $24,995 - $28,918	692 Added 3.2%	22,324 $818,000
Q1 2023 Jul 18, 2023	BUY	$39.39 - $51.28 $4,411 - $5,743	112 Added 0.5%	22,436 $915,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $25,384 - $33,136	608 Added 2.89%	21,632 $1.11 Million
Q3 2022 Nov 21, 2022	SELL	$43.76 - $53.42 $107,912 - $131,733	-2,466 Reduced 10.5%	21,024 $920,000
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $60,116 - $71,279	-1,292 Reduced 5.21%	23,490 $1.23 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $126,636 - $156,917	-2,768 Reduced 10.05%	24,782 $1.28 Million
Q4 2021 Jan 10, 2022	SELL	$41.32 - $61.25 $16,156 - $23,948	-391 Reduced 1.4%	27,550 $1.63 Million
Q3 2021 Oct 28, 2021	BUY	$39.25 - $50.42 $8,360 - $10,739	213 Added 0.77%	27,941 $1.2 Million
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $33,432 - $37,873	931 Added 3.47%	27,728 $1.09 Million
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $107,168 - $120,864	-3,200 Reduced 10.67%	26,797 $971,000
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $11,078 - $14,087	331 Added 1.12%	29,997 $1.1 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $31,718 - $37,212	-999 Reduced 3.26%	29,666 $1.09 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $2,891 - $3,507	-96 Reduced 0.31%	30,665 $1 Million
Q1 2020 May 22, 2020	SELL	$27.03 - $38.62 $5,838 - $8,341	-216 Reduced 0.7%	30,761 $1 Million
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $100,274 - $113,798	-3,046 Reduced 8.95%	30,977 $1.21 Million
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $100,524 - $130,350	3,094 Added 10.0%	34,023 $1.22 Million
Q2 2019 Jul 16, 2019	BUY	$36.98 - $41.52 $27,180 - $30,517	735 Added 2.43%	30,929 $1.34 Million
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $170,737 - $187,583	-4,553 Reduced 13.1%	30,194 $1.28 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $152,341 - $173,685	-3,960 Reduced 10.23%	34,747 $1.52 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $37,917 - $45,991	-1,100 Reduced 2.76%	38,707 $1.71 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $2.58 Million - $2.75 Million	-78,190 Reduced 66.26%	39,807 $1.44 Million
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $2.52 Million - $2.69 Million	76,441 Added 183.95%	117,997 $1.59 Million
Q1 2018 Apr 12, 2018	SELL	$31.91 - $37.02 $174,930 - $202,943	-5,482 Reduced 11.65%	41,556 $1.48 Million
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $1.46 Million - $1.61 Million	47,038	47,038 $1.68 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.

Account

Integrated Investment Consultants, LLC Pfizer Inc Transaction History